Medicare Part D Changes in 2026: Everything You Need to Know

1. The Big Picture: What Changed

Before the IRA, Medicare Part D had a famously complicated benefit structure with four phases: a deductible, initial coverage, the “donut hole” (coverage gap), and catastrophic coverage. Patients on expensive medications could face thousands of dollars in out-of-pocket costs, with no hard cap on spending.

The 2025-2026 changes fundamentally redesigned this structure:

• A hard $2,000 annual cap on out-of-pocket drug spending (effective 2025, with payment plan available 2025+)
• Medicare can now negotiate prices directly with drug manufacturers for the most expensive drugs
• The donut hole has been effectively eliminated
• Extra Help (Low-Income Subsidy) eligibility has been expanded
• Manufacturers must pay rebates if drug prices rise faster than inflation
• All Part D vaccines are now $0 (no copay)
• Insulin is capped at $35 per month

For a deeper dive into how these changes affect specific medications, check our Medicare Part D savings guide.

2. The $2,000 Out-of-Pocket Cap

This is the single most impactful change for Medicare beneficiaries. Starting in 2025, your total out-of-pocket spending on Part D prescription drugs is capped at $2,000 per year. Once you hit that threshold, you pay $0 for covered drugs for the rest of the plan year.

What Counts Toward the $2,000 Cap

• Your Part D plan deductible payments
• Copays and coinsurance for covered drugs
• Payments made during what used to be the donut hole phase

What Does NOT Count

• Your monthly Part D premium
• Costs for drugs not on your plan’s formulary
• Costs for drugs purchased at out-of-network pharmacies (unless emergency)

Who benefits most:Patients on expensive specialty medications. Before the cap, a Medicare patient taking a brand-name cancer drug could face $8,000 to $15,000 or more in annual out-of-pocket costs. Now, the maximum is $2,000 — a savings of $6,000 to $13,000 per year.

3. IRA Negotiated Drug Prices

For the first time in history, Medicare can now negotiate prices directly with pharmaceutical manufacturers for certain high-cost drugs. The first batch of negotiated prices took effect in 2026.

The First 10 Negotiated Drugs (Effective 2026)

These negotiated prices apply only to Medicare Part D beneficiaries, not to commercially insured patients. However, the negotiation process is expected to exert downward pricing pressure across the market.

An additional 15 drugs will have negotiated prices starting in 2027, and more will be added each year after that (up to 20 new drugs per year by 2029).

4. Elimination of the Donut Hole

The infamous Medicare Part D “donut hole” — the coverage gap where patients historically paid a large share of drug costs — has been effectively eliminated as of 2025.

Under the old system, after your initial coverage limit (around $5,030 in 2024), you entered the donut hole and paid 25% of brand-name drug costs until you reached the catastrophic threshold. This could mean thousands of dollars in unexpected costs for patients on expensive medications.

With the new structure, you simply pay your plan’s normal cost-sharing (copays and coinsurance) until you reach the $2,000 out-of-pocket cap, at which point you pay nothing. There is no more coverage gap to fall into.

5. Expanded Extra Help (LIS)

Extra Help (also called the Low-Income Subsidy or LIS) is a federal program that helps people with limited income and resources pay for Part D premiums, deductibles, and copays. The IRA significantly expanded eligibility starting in 2024.

What Changed

• Income threshold increased. Full Extra Help is now available to individuals with income up to 150% FPL (about $22,590 for a single person in 2026), up from the previous 135% FPL threshold.
• Partial Extra Help eliminated.Previously, people between 135% and 150% FPL received “partial” Extra Help with higher copays. Now, everyone who qualifies gets the full benefit.
• Full benefit means: $0 Part D premium (for benchmark plans), $0 deductible, and copays of $0 to $4.50 for generic drugs and $0 to $11.20 for brand-name drugs (2026 amounts).

Are you eligible? If your annual income is under approximately $22,590 (single) or $30,660 (married) and your countable resources are under $17,220 (single) or $34,360 (married), you likely qualify for full Extra Help. Apply through Social Security at ssa.gov or call 1-800-772-1213.

6. Inflation Rebates: Price Hike Penalties

Starting in 2023, drug manufacturers must pay rebates to Medicare if they raise drug prices faster than the rate of inflation. This provision applies to both Part B (physician-administered) and Part D (pharmacy) drugs.

Here is how it works: If a manufacturer raises the price of a drug by, say, 8% in a year when inflation is 3%, the manufacturer must pay Medicare a rebate equal to the difference (5%) multiplied by the number of Medicare units sold. This creates a powerful financial disincentive for excessive price increases.

The impact has been significant. In 2025 and 2026, the majority of Part D drugs had price increases at or below the inflation rate — a stark change from the pre-IRA era when annual increases of 5% to 10% were routine.

7. The Medicare Prescription Payment Plan

Starting in 2025, Medicare Part D plans must offer a “Medicare Prescription Payment Plan” that allows beneficiaries to spread their out-of-pocket drug costs evenly across the year, rather than paying large amounts upfront when filling expensive prescriptions.

For example, if you know your annual out-of-pocket drug costs will be $2,000 (the maximum), you can opt into the payment plan and pay approximately $167 per month instead of facing a large bill in January when you fill your first prescription.

This is not a loan — there are no interest charges or fees. It is simply a smoothing mechanism to make costs more predictable and manageable. You can enroll in the payment plan at any time during the year.

8. Insulin and Vaccine Coverage

Two changes that took effect earlier but remain in full force in 2026:

$35 Insulin Cap

Since 2023, the cost of insulin under Medicare Part D has been capped at $35 per month per covered insulin product. This applies regardless of whether you have met your deductible. The cap covers all insulin types — pens, vials, and biosimilars — as long as they are on your plan’s formulary.

Before the cap, some Medicare patients were paying $100 to $400 or more per month for insulin. The savings are particularly meaningful for patients on multiple insulin products.

$0 Vaccines

Since 2023, all Part D-covered vaccines have been available at $0 copay. This includes the shingles vaccine (Shingrix), which previously cost $150 to $200 out of pocket for many Medicare patients. Tetanus, pertussis, hepatitis, and other adult vaccines are also covered at $0.

9. How to Maximize Your Savings

The new Part D structure is more favorable than ever, but there are still steps you can take to pay even less:

1. Check if you qualify for Extra Help. With expanded eligibility, more people qualify than before. Even if you were denied in the past, apply again under the new income thresholds.
2. Enroll in the Payment Plan. If you take expensive medications, opt into the Medicare Prescription Payment Plan to avoid large upfront costs in January.
3. Use our drug lookup tool. Search your medications to see how negotiated prices, generics, and other savings programs affect your specific drugs.
4. Compare plans during open enrollment. The $2,000 cap is universal, but plans still differ in formularies, copay amounts, pharmacies, and premiums. Use Medicare Plan Finder to compare total estimated costs for your drug regimen.
5. Ask about biosimilars. Biosimilars for drugs like Humira and Enbrel are now widely available and are often placed on more favorable formulary tiers with lower copays.
6. Consider PAPs for non-covered drugs. If your plan does not cover a specific medication, you may still qualify for a manufacturer Patient Assistance Program.
7. Check for state assistance. Many states run Medicare Savings Programs (MSPs) that pay your Part B premiums and may cover Part D costs as well.